Deepak Nitrite reports Q2 FY26 results; highlights capacity expansion and R&D initiatives
Deepak Nitrite reported Q2 FY26 results with sequential profit improvement despite YoY declines. Strategic investments in R&D and capacity expansion aim to drive H2 growth.
The announcement covers quarterly financial results, which are always high impact. Additionally, it details substantial capital expenditure plans, the inauguration of a new R&D center, and a strategic outlook for future growth, all of which have a significant long-term impact on the company's operations and market position.
While Q2 FY26 showed sequential improvement in profitability and the company is undertaking significant strategic investments and capacity expansions for future growth, the year-on-year performance for both Q2 and H1 FY26 saw declines in revenue and profit, and the Advanced Intermediates business continues to face significant headwinds.
* Deepak Nitrite Limited (DNL) reported its Q2 & H1 FY26 results, with Q2 FY26 consolidated revenue at ₹1,922 Crore, a marginal 0.4% QoQ increase but a 6% YoY decline. * EBITDA for Q2 FY26 stood at ₹224 Crore, up 5% QoQ but down 30% YoY, with EBITDA margin improving to 12% from 11% in Q1 FY26. * Profit Before Tax (PBT) for Q2 FY26 was ₹163 Crore, a 5% QoQ increase but a 38% YoY decrease. * For H1 FY26, total revenue was ₹3,836 Crore (down 9% YoY), EBITDA ₹438 Crore (down 32% YoY), and PBT ₹318 Crore (down 41% YoY). * The Phenolics business showed strong performance with 2% sequential revenue growth and 23% QoQ EBIT growth, driven by higher volumes, better contribution, and reduced feedstock prices. * The Advanced Intermediates business faced headwinds from US tariff actions and underpriced Chinese products, leading to a 35% QoQ de-growth in EBIT. * DNL is mitigating pressures by expanding into non-traditional geographies, increasing focus on India, investing upstream, debottlenecking capacities, and implementing cost optimization. * Mr. Deepak C. Mehta, Chairman & Managing Director, noted the challenging operating landscape but highlighted the progressive performance and strategic moves towards an India-centric, import-substitution-driven business model. * He emphasized deepening integration by moving upstream into key building blocks and downstream into higher value-added applications to strengthen global competitiveness. * The company expects H2 FY26 performance to improve with the ramp-up of new capacities and market seeding of new products. * The new R&D Centre at Savli, Vadodara, built with an investment of ₹100 Crore, was inaugurated on 1st October 2025. * Major projects nearing completion include the Acid Unit and MIBK/MIBC Project, both targeted to be fully operational by Q4 FY26 (by March 31, 2026). * DNL is also progressing on a large-scale CAPEX program, including India’s first integrated Polycarbonate plant (165,000 MT/yr) with a total investment of ₹8,500 Crore, and new capacities of Phenol, Acetone, and IPA, expected to be fully operational by FY27.
What to do with a filing like this
Deepak Nitrite Limited filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it high impact, which is the band that most often changes something.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Deepak Nitrite Limited. Read the original for the full detail.